Clinical Research Directory
Browse clinical research sites, groups, and studies.
Molecularly Redefining Small Bowel Adenocarcinoma to Accelerate Precision Patient Care
Sponsor: Copenhagen University Hospital at Herlev
Summary
Small bowel adenocarcinoma is a rare malignancy, and there is limited knowledge about its optimal clinical management and molecular background. The SBAMOL study is an observational biomarker study that aims to identify prognostic and predictive biomarkers. This effort is intended to lay the groundwork for personalized medicine tailored to this specific patient group.
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
500
Start Date
2024-01-01
Completion Date
2033-12-31
Last Updated
2024-01-31
Healthy Volunteers
No
Conditions
Locations (3)
Department of Oncology, Aarhus University Hospital
Aarhus N, Denmark
Department Surgical Gastroenterology, Copenhagen University Hospital - Rigshospitalet
Copenhagen Ø, Denmark
Department of Oncology Copenhagen University Hospital - Herlev and Gentofte
Herlev, Denmark